VYZULTA

bausch & lomb inc🇨🇦 Health Canada

Approval Id: d13f71da7a22ad8c
Drug Approval Canada Name: VYZULTA
Product Name: VYZULTA
Status: Marketed
Status Date: 2019-05-17
Original Market Date: 2019-05-17
Din: 02484218
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Ophthalmic
Schedule: Prescription
Ahfs: 52:40.28
Atc Original: S01EE06 LATANOPROSTENE BUNOD
Atc Name: s 01 ee 06
Aig Number: 0161070001
Company Name: bausch & lomb inc
Company Address: 1400 N Goodman Street, Rochester, New York, United States, 14609

LATANOPROSTENE BUNOD

0.024 % / W/V

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d13f71da7a22ad8c

Type

Standard